Cargando…

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015

BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as an important cause of healthcare-associated infections. We characterized the molecular epidemiology of CRE in isolates collected through the Emerging Infections Program (EIP) at the Centers for Disease Control and Prevention (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Uzma, Lawsin, Adrian, Campbell, Davina, Albrecht, Valerie, McAllister, Gillian, Bulens, Sandra, Walters, Maroya Spalding, Jacob, Jesse T, Satola, Sarah W, Wilson, Lucy E, Lynfield, Ruth, Vagnone, Paula M Snippes, Janelle, Sarah J, Xavier, Karen, Dumyati, Ghinwa, Hardy, Dwight, Phipps, Erin C, Culbreath, Karissa, Beldavs, Zintars, Morey, Karim, Kainer, Marion A, Roberts, Sheri, Kallen, Alexander, Rasheed, J Kamile, Karlsson, Maria S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631811/
http://dx.doi.org/10.1093/ofid/ofx163.328
_version_ 1783269564795060224
author Ansari, Uzma
Lawsin, Adrian
Campbell, Davina
Albrecht, Valerie
McAllister, Gillian
Bulens, Sandra
Walters, Maroya Spalding
Jacob, Jesse T
Satola, Sarah W
Wilson, Lucy E
Lynfield, Ruth
Vagnone, Paula M Snippes
Janelle, Sarah J
Xavier, Karen
Dumyati, Ghinwa
Hardy, Dwight
Phipps, Erin C
Culbreath, Karissa
Beldavs, Zintars
Morey, Karim
Kainer, Marion A
Roberts, Sheri
Kallen, Alexander
Rasheed, J Kamile
Karlsson, Maria S
author_facet Ansari, Uzma
Lawsin, Adrian
Campbell, Davina
Albrecht, Valerie
McAllister, Gillian
Bulens, Sandra
Walters, Maroya Spalding
Jacob, Jesse T
Satola, Sarah W
Wilson, Lucy E
Lynfield, Ruth
Vagnone, Paula M Snippes
Janelle, Sarah J
Xavier, Karen
Dumyati, Ghinwa
Hardy, Dwight
Phipps, Erin C
Culbreath, Karissa
Beldavs, Zintars
Morey, Karim
Kainer, Marion A
Roberts, Sheri
Kallen, Alexander
Rasheed, J Kamile
Karlsson, Maria S
author_sort Ansari, Uzma
collection PubMed
description BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as an important cause of healthcare-associated infections. We characterized the molecular epidemiology of CRE in isolates collected through the Emerging Infections Program (EIP) at the Centers for Disease Control and Prevention (CDC). METHODS: From 2011–2015, 8 U.S. EIP sites (CO, GA, MD, MN, NY, NM, TN and OR) collected CRE (Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, and Klebsiella oxytoca) isolated from a normally sterile site or urine. Isolates were sent to CDC for reference antimicrobial susceptibility testing and real-time PCR detection of carbapenemase genes (bla(KPC), bla(NDM), bla(OXA-48)). Phenotypically confirmed CRE were analyzed by whole genome sequencing (WGS) using an Illumina MiSeq benchtop sequencer. RESULTS: Among 639 Enterobacteriaceae evaluated, 414 (65%) were phenotypically confirmed as CRE using CDC’s current surveillance definition (resistant to ertapenem, imipenem, doripenem, or meropenem). Among isolates confirmed as CRE, 303 (73%) were carbapenemase-producers (CP-CRE). The majority of CP-CRE originated from GA (39%), MD (35%) and MN (11%); most non-CP-CREs originated from MN (27%), CO (25%) and OR (17%). K. pneumoniae was the predominant carbapenemase-producing species (78%) followed by E. cloacae complex spp (12%), E. coli (7.9%), E. Aerogenes (0.9%) and K. oxytoca (0.6%). The most common carbapenemase genes detected were bla(KPC-3) (76%) and bla(KPC-2) (19%); bla(NDM) and bla(OXA-48)-like genes were detected in 1.6% and 0.3% of isolates, respectively. For carbapenemase-producing K. pneumoniae, Enterobacter spp, and E. coli, the predominant sequence types (ST) were ST258 (65%), ST171 (35%) and ST131 (29%), respectively. CONCLUSION: The distribution of CP and non-CP-CRE varied across the catchment sites. Among CP-CRE, KPC-producing K. pneumoniae predominated; other carbapenemases were rarely identified in the locations under surveillance. Strain types known to have increased epidemic potential (ST258 and ST131) were common among carbapenemase-producing K. pneumoniae and E. coli isolates, respectively. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5631811
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56318112017-11-07 Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015 Ansari, Uzma Lawsin, Adrian Campbell, Davina Albrecht, Valerie McAllister, Gillian Bulens, Sandra Walters, Maroya Spalding Jacob, Jesse T Satola, Sarah W Wilson, Lucy E Lynfield, Ruth Vagnone, Paula M Snippes Janelle, Sarah J Xavier, Karen Dumyati, Ghinwa Hardy, Dwight Phipps, Erin C Culbreath, Karissa Beldavs, Zintars Morey, Karim Kainer, Marion A Roberts, Sheri Kallen, Alexander Rasheed, J Kamile Karlsson, Maria S Open Forum Infect Dis Abstracts BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as an important cause of healthcare-associated infections. We characterized the molecular epidemiology of CRE in isolates collected through the Emerging Infections Program (EIP) at the Centers for Disease Control and Prevention (CDC). METHODS: From 2011–2015, 8 U.S. EIP sites (CO, GA, MD, MN, NY, NM, TN and OR) collected CRE (Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, and Klebsiella oxytoca) isolated from a normally sterile site or urine. Isolates were sent to CDC for reference antimicrobial susceptibility testing and real-time PCR detection of carbapenemase genes (bla(KPC), bla(NDM), bla(OXA-48)). Phenotypically confirmed CRE were analyzed by whole genome sequencing (WGS) using an Illumina MiSeq benchtop sequencer. RESULTS: Among 639 Enterobacteriaceae evaluated, 414 (65%) were phenotypically confirmed as CRE using CDC’s current surveillance definition (resistant to ertapenem, imipenem, doripenem, or meropenem). Among isolates confirmed as CRE, 303 (73%) were carbapenemase-producers (CP-CRE). The majority of CP-CRE originated from GA (39%), MD (35%) and MN (11%); most non-CP-CREs originated from MN (27%), CO (25%) and OR (17%). K. pneumoniae was the predominant carbapenemase-producing species (78%) followed by E. cloacae complex spp (12%), E. coli (7.9%), E. Aerogenes (0.9%) and K. oxytoca (0.6%). The most common carbapenemase genes detected were bla(KPC-3) (76%) and bla(KPC-2) (19%); bla(NDM) and bla(OXA-48)-like genes were detected in 1.6% and 0.3% of isolates, respectively. For carbapenemase-producing K. pneumoniae, Enterobacter spp, and E. coli, the predominant sequence types (ST) were ST258 (65%), ST171 (35%) and ST131 (29%), respectively. CONCLUSION: The distribution of CP and non-CP-CRE varied across the catchment sites. Among CP-CRE, KPC-producing K. pneumoniae predominated; other carbapenemases were rarely identified in the locations under surveillance. Strain types known to have increased epidemic potential (ST258 and ST131) were common among carbapenemase-producing K. pneumoniae and E. coli isolates, respectively. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631811/ http://dx.doi.org/10.1093/ofid/ofx163.328 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Ansari, Uzma
Lawsin, Adrian
Campbell, Davina
Albrecht, Valerie
McAllister, Gillian
Bulens, Sandra
Walters, Maroya Spalding
Jacob, Jesse T
Satola, Sarah W
Wilson, Lucy E
Lynfield, Ruth
Vagnone, Paula M Snippes
Janelle, Sarah J
Xavier, Karen
Dumyati, Ghinwa
Hardy, Dwight
Phipps, Erin C
Culbreath, Karissa
Beldavs, Zintars
Morey, Karim
Kainer, Marion A
Roberts, Sheri
Kallen, Alexander
Rasheed, J Kamile
Karlsson, Maria S
Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
title Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
title_full Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
title_fullStr Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
title_full_unstemmed Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
title_short Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
title_sort molecular characterization of carbapenem-resistant enterobacteriaceae in the usa, 2011–2015
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631811/
http://dx.doi.org/10.1093/ofid/ofx163.328
work_keys_str_mv AT ansariuzma molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT lawsinadrian molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT campbelldavina molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT albrechtvalerie molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT mcallistergillian molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT bulenssandra molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT waltersmaroyaspalding molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT jacobjesset molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT satolasarahw molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT wilsonlucye molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT lynfieldruth molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT vagnonepaulamsnippes molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT janellesarahj molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT xavierkaren molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT dumyatighinwa molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT hardydwight molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT phippserinc molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT culbreathkarissa molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT beldavszintars molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT moreykarim molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT kainermariona molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT robertssheri molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT kallenalexander molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT rasheedjkamile molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015
AT karlssonmarias molecularcharacterizationofcarbapenemresistantenterobacteriaceaeintheusa20112015